Indivior | GJELD



Debt Endring Dato
AstraZeneca USD 30.3B 1.27B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Indivior 284M 3M 2024-09
J&J USD 36.63B 883M 2024-12
Kyowa Hakko Kirin JPY 28.75B 5.04B 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Sanofi 23.75B 5.33B 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12



Indivior GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.